Opportunity Information: Apply for CDC RFA GH15 1520
Apply for CDC RFA GH15 1520
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Improving PMTCT and Quality of HIV Treatment and STI Surveillance and Increasing Capacity to Address Needs for Key Populations in the Dominican Republic Ministry of Health under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Oct 23, 2014 and posted on Sep 11, 2014.
- Applicants must submit their applications by Dec 3, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $835,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this FOA are listed below The Ministry of Health (MOH) of the Dominican Republic
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, funded through the US Centers for Disease Control and Prevention (CDC) under the Presidents Emergency Plan for AIDS Relief (PEPFAR), is designed to strengthen the Dominican Republic Ministry of Healths national response to HIV and sexually transmitted infections. The announcement focuses on four connected priorities: improving prevention of mother-to-child transmission (PMTCT) services, raising the quality of HIV treatment services, improving STI surveillance and treatment, and building stronger capacity within the National HIV/STI Program to address the needs and strategic issues affecting key populations. The overall intent is national impact, meaning the work is meant to reinforce systems, policies, and service quality across the country rather than supporting isolated local projects.
At the service-delivery level, a major goal is to improve PMTCT so that fewer infants acquire HIV and pregnant people living with HIV receive consistent, effective care. This generally includes strengthening how pregnant patients are identified and tested, ensuring rapid linkage to HIV care, supporting consistent antiretroviral treatment during pregnancy and breastfeeding as appropriate, and improving follow-up for HIV-exposed infants. In practice, these kinds of awards often aim to close gaps in the PMTCT cascade, such as late entry into antenatal care, incomplete testing, delays in starting treatment, weak retention through delivery and postpartum periods, and missed early infant diagnosis. The emphasis on PMTCT signals a push to make maternal and child health and HIV services work better together, with clearer referral pathways and more reliable monitoring of outcomes.
The opportunity also targets the quality of HIV treatment services. Rather than simply expanding the number of patients on treatment, the focus is on how well treatment programs perform. That typically means improving clinical practices, supporting adherence and retention, ensuring timely viral load monitoring when available, strengthening patient tracking systems, and promoting consistent use of standards and guidelines across facilities. The phrase improving the quality of HIV treatment services suggests an emphasis on measurable improvements in clinical outcomes and program performance, including reducing treatment interruptions and ensuring patients remain engaged in care over time. Because this is framed as a national strengthening effort, it is likely intended to bolster the Ministrys ability to set standards, supervise service delivery, and use data to identify and fix performance problems.
A third objective is to improve STI surveillance and treatment services. This points to both stronger detection of STIs and better reporting and data use, since surveillance depends on consistent case identification, standardized reporting, and the ability to analyze trends over time. Improved STI services often include strengthening syndromic management where laboratory access is limited, expanding diagnostic capacity where feasible, improving treatment availability and adherence to guidelines, and integrating STI services with HIV prevention and care. Better STI surveillance helps the health system understand where transmission risks are highest, which populations are most affected, and where to target prevention, testing, and treatment resources.
The fourth priority is increasing capacity to address the needs of key populations (KP) within the National Program. Key populations typically refers to groups disproportionately affected by HIV and other STIs and who may face barriers to care because of stigma, discrimination, legal constraints, or social marginalization. The FOA describes creating capacity in the National Program to address strategic issues for KP, which signals work at the policy, planning, and program-management level, such as improving how the Ministry designs services that are accessible and acceptable to these communities, ensuring program data can highlight inequities and service gaps, and supporting coordination with partners who deliver or facilitate KP-friendly services. The underlying theme is that a national HIV/STI response will not achieve epidemic control without addressing the populations most impacted and the structural barriers that keep them from consistent prevention and treatment.
This award is structured as a cooperative agreement, meaning CDC would be expected to have substantial involvement beyond standard grant oversight, often through technical assistance, joint planning, and ongoing collaboration on implementation and performance monitoring. The funding activity category is health, and it is associated with CFDA number 93.067 (Global AIDS), aligning it directly with PEPFAR programming goals and reporting expectations. The FOA notes that the activities contribute to all three priority areas in the PEPFAR/Dominican Republic Results Framework, indicating alignment with the countrys PEPFAR strategy and expected performance indicators.
Administratively, the FOA was posted on September 11, 2014, created on October 23, 2014, with the original closing date of November 17, 2014, later extended to December 3, 2014, and archived on December 17, 2014. The expected number of awards is one, reinforcing that this is a single, nationally focused agreement rather than multiple competing projects. The award ceiling is listed as USD 835,000, with no cost-sharing or matching requirement. Eligibility is explicitly limited to the Dominican Republic Ministry of Health, making this a direct government-to-government capacity strengthening opportunity rather than an open competition for NGOs, universities, or other implementers.
For access issues with the full announcement, the contact listed is the CDC Procurement and Grants Office, Technical Information Management Section, with a phone number provided. Overall, the opportunity is best understood as a targeted investment in national systems and service quality for PMTCT, HIV treatment, STI surveillance and care, and key population programming, delivered through close collaboration between CDC and the Dominican Republic Ministry of Health under the broader PEPFAR agenda.
Frequently Asked Questions (FAQs)
1) What is this grant opportunity about?
This is a CDC-funded grant opportunity under the US President's Emergency Plan for AIDS Relief (PEPFAR) to strengthen the Dominican Republic Ministry of Health's national response to HIV and sexually transmitted infections (STIs). The intent is national impact by reinforcing systems, policies, and service quality across the country.
2) Who is funding this opportunity?
The opportunity is funded through the US Centers for Disease Control and Prevention (CDC) and aligned with PEPFAR programming.
3) What type of award is this?
This award is a cooperative agreement, meaning CDC is expected to have substantial involvement beyond standard grant oversight, such as technical assistance, joint planning, and ongoing collaboration on implementation and performance monitoring.
4) What are the main program priorities in the announcement?
The announcement emphasizes four connected priorities:
- Improving prevention of mother-to-child transmission (PMTCT) services
- Raising the quality of HIV treatment services
- Improving STI surveillance and treatment
- Building stronger capacity within the National HIV/STI Program to address the needs and strategic issues affecting key populations
5) Is this focused on local projects or national systems?
It is designed for national impact. The work is intended to reinforce systems, policies, and service quality across the Dominican Republic rather than supporting isolated local projects.
6) What does "improving PMTCT services" mean in practice?
The PMTCT focus is aimed at reducing infant HIV acquisition and ensuring pregnant people living with HIV receive consistent, effective care. Activities generally include strengthening identification and testing of pregnant patients, rapid linkage to HIV care, supporting consistent antiretroviral treatment during pregnancy and breastfeeding as appropriate, and improving follow-up for HIV-exposed infants.
7) What gaps in the PMTCT cascade does the opportunity aim to address?
The announcement highlights typical PMTCT cascade gaps such as late entry into antenatal care, incomplete testing, delays in starting treatment, weak retention through delivery and postpartum periods, missed early infant diagnosis, and weak follow-up of HIV-exposed infants.
8) How does the opportunity relate to maternal and child health services?
The emphasis on PMTCT signals a push to strengthen integration between maternal and child health services and HIV services, including clearer referral pathways and more reliable monitoring of outcomes.
9) What does "improving the quality of HIV treatment services" involve?
The opportunity focuses on how well treatment programs perform rather than only increasing the number of patients on treatment. This typically includes improving clinical practices, supporting adherence and retention, ensuring timely viral load monitoring when available, strengthening patient tracking systems, and promoting consistent use of standards and guidelines across facilities.
10) What kinds of outcomes are implied by "quality" improvements in HIV treatment?
The description suggests measurable improvements in clinical outcomes and program performance, including reducing treatment interruptions and ensuring patients remain engaged in care over time.
11) How is STI surveillance and treatment addressed by this opportunity?
The opportunity targets stronger detection of STIs and better reporting and data use. It points to consistent case identification, standardized reporting, and the ability to analyze trends over time, alongside strengthening treatment services.
12) What kinds of STI service improvements are referenced?
Examples described include strengthening syndromic management where laboratory access is limited, expanding diagnostic capacity where feasible, improving treatment availability and adherence to guidelines, and integrating STI services with HIV prevention and care.
13) Why is improving STI surveillance important in the context of HIV programming?
Better STI surveillance can help the health system understand where transmission risks are highest, which populations are most affected, and where to target prevention, testing, and treatment resources.
14) What does the opportunity mean by "key populations" (KP)?
Key populations are described as groups disproportionately affected by HIV and other STIs who may face barriers to care due to stigma, discrimination, legal constraints, or social marginalization.
15) What does it mean to "build capacity" within the National HIV/STI Program for key populations?
The announcement signals work at the policy, planning, and program-management level to better address strategic issues affecting key populations. Examples include improving how services are designed to be accessible and acceptable, ensuring program data can highlight inequities and service gaps, and supporting coordination with partners who deliver or facilitate KP-friendly services.
16) How does this opportunity align with broader PEPFAR goals?
It is associated with CFDA 93.067 (Global AIDS) and is described as contributing to all three priority areas in the PEPFAR/Dominican Republic Results Framework, indicating alignment with the country's PEPFAR strategy and expected performance indicators.
17) What is the CFDA number for this opportunity?
The CFDA number listed is 93.067 (Global AIDS).
18) What is the funding activity category?
The funding activity category is health.
19) How many awards are expected?
The expected number of awards is one, indicating a single, nationally focused agreement rather than multiple awards for separate projects.
20) What is the maximum (ceiling) amount for the award?
The award ceiling is listed as USD 835,000.
21) Is cost sharing or matching required?
No. The announcement states there is no cost-sharing or matching requirement.
22) Who is eligible to apply?
Eligibility is explicitly limited to the Dominican Republic Ministry of Health. It is not an open competition for NGOs, universities, or other implementers.
23) What were the key posted and closing dates mentioned?
The FOA was posted on September 11, 2014, created on October 23, 2014, originally closed on November 17, 2014, and later extended to December 3, 2014. It was archived on December 17, 2014.
24) Who is the contact for access issues with the full announcement?
The contact listed is the CDC Procurement and Grants Office, Technical Information Management Section, with a phone number provided in the announcement for access issues.
25) What is the overall intent of the award in one sentence?
The award is a targeted investment in national systems and service quality for PMTCT, HIV treatment, STI surveillance and care, and key population programming, implemented through close collaboration between CDC and the Dominican Republic Ministry of Health under the broader PEPFAR agenda.
Browse more opportunities from the same category: Health
Next opportunity: Strengthening the Capacity of the Republican AIDS Center to Implement HIV Program in the Republic of Tajikistan under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Strengthening the Capacity of Faith based organizations (FBOs) and Faith Based Health Systems to Sustain the Role of FBOs in a Coordinated Response to HIV/AIDS
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1520
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1520) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening the Capacity of the Republican AIDS Center to Implement HIV Program in the Republic of Tajikistan under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1514 Funding Number: CDC RFA GH15 1514 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Supporting HIV and Tuberculosis Response in the Kingdom of Lesotho through District based Comprehensive Prevention, Care and Treatment Programs and Health Systems Strengthening under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1548 Funding Number: CDC RFA GH15 1548 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Technical Assistance for Laboratory Systems Strengthening in Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1560 Funding Number: CDC RFA GH15 1560 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Request to Access Parkinsons Disease Related Biospecimens (X01) Apply for PAR 14 340 Funding Number: PAR 14 340 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epigenetic Analyses of Aging as a Risk Factor for Multiple Chronic Conditions (U34) Apply for RFA AG 15 004 Funding Number: RFA AG 15 004 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| NIAID Career Transition Award (K22) Apply for PAR 14 341 Funding Number: PAR 14 341 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical and Translational Science Award (U54) Apply for RFA TR 14 009 Funding Number: RFA TR 14 009 Agency: National Institutes of Health Category: Health Funding Amount: $10,000,000 |
| Immunization Information Systems (IIS) Apply for CDC RFA IP13 130203CONT15 Funding Number: CDC RFA IP13 130203CONT15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Capacity Building of Provincial Health Directorates (DPSs) in Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1561 Funding Number: CDC RFA GH15 1561 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Strengthening the Delivery, Coordination, and Monitoring of HIV Services in Malawi through Faith based Institutions under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1550 Funding Number: CDC RFA GH15 1550 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,100,000 |
| South African University based Technical Assistance Aimed at Improving the quality of HIV/AIDS and related services in the Republic of South Africa under the United States Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1574 Funding Number: CDC RFA GH15 1574 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Improving Medical Education in Malawi under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1552 Funding Number: CDC RFA GH15 1552 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Support of Civil Registration and Vital Statistics in Malawi through the National Registration Bureau under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1554 Funding Number: CDC RFA GH15 1554 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Building Effective Health Information Systems under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1535 Funding Number: CDC RFA GH15 1535 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,600,000 |
| Technical Assistance and Support for the Development and Implementation of Key Aspects of HIV/AIDS Care and Support Services in South Africa under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1578 Funding Number: CDC RFA GH15 1578 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $6,500,000 |
| Peer to Peer Capacity Building in the Public Sector to Support Management, Leadership, and Sustainability of HIV Programs in PEPFAR Countries under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1532 Funding Number: CDC RFA GH15 1532 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support (NAM PHACTS) under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1615 Funding Number: CDC RFA GH15 1615 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Analyses of Datasets on Older Populations with High Prevalence of Mobility Disability to Develop Clinically Meaningful Diagnostic Cut Points for Low Muscle Mass and/or Low Muscle Strength (U01) Apply for RFA AG 15 013 Funding Number: RFA AG 15 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 15 012 Funding Number: HRSA 15 012 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 15 013 Funding Number: HRSA 15 013 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1520", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.